Differential diagnosis of chronic urticaria

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 3, 2008, Pages 181-188

  Brodell, Lindsey A ^a   Beck, Lisa A ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; BULLOUS PEMPHIGOID; CHRONIC URTICARIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; IDIOPATHIC DISEASE; LABORATORY TEST; LUPUS ERYTHEMATOSUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; URTICARIA PIGMENTOSA;

EID: 40849104961     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60438-3     Document Type: Review

References (57)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664-672.
2. Kaplan AP. Clinical practice: chronic urticaria and angioedema. N Engl J Med. 2002;346:175-179.
3. Barlow RJ, Warburton F, Watson K, Black AK, Greaves MW. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol. 1993;29:954-958.
4. Black AK, Lawlor F, Greaves MW. Consensus meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol. 1996;21:424-426.
5. Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol. 2002;46:645-657; quiz 57-60.
6. Friedmann PS. Assessment of urticaria and angio-oedema. Clin Exp Allergy. 1999;29(suppl 3):109-12; discussion 13-5.
7. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol. 1998;134:1575-1580.
8. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol. 2001;45:387-391.
9. Sabroe RA, Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol. 1997;133:1003-1008.
10. Mobini N, Toussiant S, Kamino H. Lever's Histopathology of the Skin. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
11. Synkowski DR, Levine MI, Rabin BS, Yunis EJ. Urticaria: an immunofluorescence and histopathology study. Arch Dermatol. 1979;115:1192-1194.
12. Barlow RJ, Ross EL, MacDonald D, Black AK, Greaves MW. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol. 1994;131:341-347.
13. de Castro FR, Masouye I, Winkelmann RK, Saurat JH. Urticarial pathology in Schnitzler's (hyper-IgM) syndrome. Dermatology. 1996;193:94-99.
14. Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol. 2006;18:108-117.
15. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301-305.
16. Stankovic K, Grateau G. Autoinflammatory syndromes: diagnosis and treatment. Joint Bone Spine. 2007;74:544-550.
17. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50:607-612.
18. Lieberman A, Grossman ME, Silvers DN. Muckle-Wells syndrome: case report and review of cutaneous pathology. J Am Acad Dermatol. 1998;39:290-291.
19. Dode C, Le Du N, Cuisset L, et al. New mutations of ClAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet. 2002;70:1498-1506.
20. Nazzari G, Desirello G, Crovato F. Recurrent urticarial skin eruption since infancy: Muckle-Wells syndrome (MWS). Arch Dermatol. 1995;131:81-82, 4-5.
21. Haas N, Kuster W, Zuberbier T, Henz BM. Muckle-Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol. 2004;151:99-104.
22. Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol. 2007;33:1-9.
23. Leslie KS, Lachmann HJ, Bruning E, et al. Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with ClAS-1/NALP3 mutations. Arch Dermatol. 2006;142:1591-1597.
24. Schnitzler L, Hurez D, Verret JL. Chronic urticaria-osteocondensation- macroglobulinemia: principal case: study of 20 cases. Ann Dermatol Venereol. 1989;116:547-550.
25. Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol. 2008;121:260-262.
26. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome: four new cases and review of the literature. Medicine (Baltimore). 2001;80:37-44.
27. Costner MI, Sontheimer RD. Lupus Erythematosus. 6th ed. Philadelphia, PA: McGraw Hill; 2003.
28. Costner MI, Grau RH. Update on connective tissue diseases in dermatology. Semin Cutan Med Surg. 2006;25:207-220.
29. Lyon CC, Blewitt R, Harrison PV. Subacute cutaneous lupus erythematosus: two cases of delayed diagnosis. Acta Derm Venereol. 1998;78:57-59.
30. Chlebus E, Wolska H, Blaszczyk M, Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol. 1998;38:405-412.
31. Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol. 2006;47:13-27.
32. Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol. 1992;26:441-448.
33. Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol. 2000;12:24-31.
34. Venzor J, Lee WL, Huston DP. Urticarial vasculitis. Clin Rev Allergy Immunol. 2002;23:201-216.
35. Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin Dermatol. 2004;22:121-124.
36. Mehregan DR, Gibson LE. Pathophysiology of urticarial vasculitis. Arch Dermatol. 1998;134:88-89.
37. Stone JH. The Systemic Vasculitites. Philadelphia, PA: Elsevier Science; 2003.
38. Davis MD, Daoud MS, Kirby B, Gibson LE, Rogers RS III. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol. 1998;38:899-905.
39. Botsios C, Sfriso P, Ostuni PA, Todesco S, Punzi L. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis: report of two cases. Rheumatology. 2007;46:1042-1043.
40. Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology. 2007;74:121-132.
41. Sperr WR, Jordan JH, Fiegl M, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128:136-141.
42. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-625.
43. Wolff K, Komar M, Petzelbauer P. Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res. 2001;25:519-528.
44. Wolff K. Treatment of cutaneous mastocytosis. Int Arch Allergy Immunol. 2002;127:156-159.
45. Sweet RD. Acute febrile neutrophilic dermatosis-1978. Br J Dermatol. 1979;100:93-99.
46. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31:535-556; quiz 57-60.
47. von den Driesch P, Gomez RS, Kiesewetter F, Hornstein OP. Sweet's syndrome: clinical spectrum and associated conditions. Cutis. 1989;44:193-200.
48. Cohen PR, Kurzrock R. Sweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol. 2000;18:265-282.
49. Shiohara T, Mizukawa Y. Fixed drug eruption: easily overlooked but needing new respect. Dermatology. 2002;205:103-104.
50. Shiohara T, Mizukawa Y, Teraki Y. Pathophysiology of fixed drug eruption: the role of skin-resident T cells. Curr Opin Allergy Clin Immunol. 2002;2:317-323.
51. Korkij W, Soltani K. Fixed drug eruption: a brief review. Arch Dermatol. 1984;120:520-524.
52. Hadi SM, Barnetson RS, Gawkrodger DJ, Saxena U, Bird P, Merrett TG. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica. 1988;176:6-17.
53. Provost TT, Tomasi TB Jr. Immunopathology of bullous pemphigoid: basement membrane deposition of IgE, alternate pathway components and fibrin. Clin Exp Immunol. 1974;18:193-200.
54. Arbesman CE, Wypych JI, Reisman RE, Beutner EH. IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch Dermatol. 1974;110:378-381.
55. Fairley JA, Burnett CT, Fu CL, Larson DL, Fleming MG, Giudice GJ. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J Invest Dermatol. 2007;127:2605-2611.
56. Steigleder GK, Gartmann H, Linker U. REM syndrome: reticular erythematous mucinosis (round-cell erythematosis), a new entity? Br J Dermatol. 1974;91:191-199.
57. Cohen PR, Rabinowitz AD, Ruszkowski AM, DeLeo VA. Reticular erythematous mucinosis syndrome: review of the world literature and report of the syndrome in a prepubertal child. Pediatr Dermatol. 1990;7:1-10.